Increasing Prevalence of Chronic Diseases
Increased incidence of chronic and age-related diseases is a significant driver of the infusion pump market. Diabetes, cancer, cardiovascular disease, and autoimmune disorders often necessitate precise, controlled, and continuous medication delivery, which infusion pumps facilitate. Nearly 6 in 10 US adults have at least one chronic disease, and 4 out of 10 have two or more. The International Diabetes Federation also stated that 537 million adults globally were living with diabetes in 2021, a figure estimated to rise to 643 million in 2030 & 783 million in 2045, the overwhelming need of insulin pumps or other types of infusion therapy. Similarly, the increasing global burden of cancer, often involving chemotherapy by infusion, also follows this pattern. A steady demand for infusion pumps is fuelled by demand for sophisticated medical equipment used to treat such patients suffering from chronic conditions.
Increased Home Healthcare Use
The trend of providing healthcare services away from the standard hospital environment, specifically in the patient's home, is a major stimulant to the infusion pump market. This is driven by a number of reasons, some of which include reducing costs, patients' desire for convenience and comfort, and attempts to reduce the acute care burden. The infusion pumps are at the core of making such a transition possible so that patients can be given essential therapies such as intravenous antibiotics, pain control, and feeding from the safety of their homes. Steady growth in the use of home health devices is witnessed, with millions of home health beneficiaries annually. This is particularly true for an aging population, where older patients desire to age in place but continue to have access to the medical care they require. The development of easy-to-use, portable, and intelligent infusion pumps for home use adds to this paradigm shift again, expanding the market access outside the clinical environment.
Technology Advances and Smart Pump Adoption
Radical opportunities in the infusion pump market accompany continuous technology enhancement, in particular, the adoption of smart technologies and enhanced connectivity. The shift to intelligent pumps, with drug libraries, dose error reduction systems (DERS), and wireless communication, is revolutionizing patient safety and clinical effectiveness. These pumps will reduce drug errors by a tremendous margin, a healthcare priority of the highest order. As one leading U.S. regulatory body demands, such technologies must be employed to improve healthcare outcomes. The ability of these devices to integrate with electronic health records (EHRs) & hospital information systems (HIS) without hitches simplifies workflows, enhances data accuracy, and enables remote monitoring. Opportunities such as data analysis in real-time, predictive maintenance, and cyber security features are becoming ever more critical, making way for new product development & market expansion. As healthcare systems evolve to be more safety- and efficiency-focused, there will be demand for highly smart and interoperable infusion solutions that will drive significant growth opportunities.
Growth in Emerging Economies
Emerging economies offers vast & largely untapped opportunity, fuelled by booming healthcare infrastructure, increasing healthcare expenditure, and expanding awareness of advanced medical therapies. Asia-Pacific, Latin American, and African economies are experiencing robust economic growth, increased disposable income, and increased willingness to spend on good health. Their governments are also initiating drives to make healthcare more accessible and upgrade medical facilities, including treatment facilities. The increased prevalence of chronic ailments in these groups, and increasing numbers of private health providers, create a fertile ground for entry and expansion. While regulatory complexity and pricing sensitivity still exist, patient volumes and unmet medical needs in these areas represent a long-term growth trend for infusion pump manufacturers.
The following Key Market Indicators present a comprehensive overview of the social and economic landscape of the selected region, offering critical insights into market-specific trends and developments. These indicators, combined with data from government statistics, industry associations, and corporate sources, form the analytical foundation of NextGen Intelligence Stats' market models.
| Aspects | Details |
Base Year
|
2024 |
Historic Data
|
2021-2023 |
Forecast Period
|
2025-2035 |
Regions & Countries Covered
|
North America (United States, Canada), Europe (Germany, France, Italy, United Kingdom, Spain, Rest of Europe), Asia Pacific (China, Japan, South Korea, India, Rest of Asia Pacific), Latin America (Brazil, Argentina, Rest of Latin America), Middle East& |
Companies Profiles
|
|
Segmentation Level Customization
|
Additional Segments and Sub Segment |
Company Level Customization
|
Market share analysis at country levels |
Country level Data Customization
|
Segmental volume analysis Pricing Analysis of Product Company Market Share |
In January 2024, Abbott Laboratories introduced its newest innovation in infusion technology with the release of the Abbott SmartPump. This next-generation smart infusion pump has been designed to advance medication delivery accuracy and patient safety through cutting-edge monitoring capabilities.
In February 2024, Johnson & Johnson and Hospira made a strategic partnership to co-develop and provide integrated infusion solutions. The partnership aims to enhance treatment efficiency and patient outcomes through the integration of Hospira's infusion system know-how with pharmaceutical innovation by Johnson & Johnson.
In March 2024, CME Medical extended its manufacturing presence with the launch of a new site in Austin, Texas. The expansion is meant to ramp up the production of its infusion pumps and address growing global demand, mainly in North America.
In May 2024, Mindray roll out its newest innovation in infusion technology—the InfuSmart 3000, a cutting-edge infusion pump that caters to the increasing need for networked healthcare solutions. The new product has wireless connectivity, making it easy to integrate into hospital networks as well as electronic health records (EHRs).
In June 2024, Terumo embarked on a major strategic initiative with the acquisition of Codman and Shurtleff, a respected brand in medical devices with a reputation for producing neuro and infusion therapy products. The acquisition greatly enhances Terumo's portfolio of infusion therapy, providing it with more diversity in terms of next-generation technologies and further establishing its presence in the North American and European markets.
The infusion pump market is globally competitive led by Abbott Laboratories, Hospira, and Medtronic. They are focusing on innovation & technological advancements to continually enhance their products & maintain leadership status. Manufacturers are launching a new series of smart infusion pumps that interface with electronic health records to optimize medication management & patient safety. Additionally, companies are forming strategic partnerships & collaborations to expand market share. Giants are forming partnerships with several healthcare providers to enable its infusion systems adoption. Competition is once again increased by new entrants and continued technological development, forcing current companies to innovate and transform
• BD
• Nipro
• Teleflex Incorporated
• Baxter
• AVNS
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd
• B. Braun SE
• Insulet Corporation
• ICU Medical, Inc.
• Tandem Diabetes Care, Inc.
• Ypsomed
• Fresenius Kabi AG
• JMS Co., Ltd.
• Polymedicure
• Medtronic
• F. Hoffmann-La Roche Ltd.
• Romsons
• Terumo Corporation
• Moog, Inc.
• Promed Technology Co., Limited
• Medcaptain Medical Technology Co., Ltd.
• Others
The global Infusion Pump market size accounted for USD 12.45 billion in 2024 and it is expected to reach around USD 27.30 billion by 2035.
The global Infusion Pump market is poised to grow at a CAGR of 7.1% from 2025 to 2035.
North America region accounted for largest market share in the Infusion Pump Market.
BD, Nipro, Teleflex Incorporated, Baxter, AVNS, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, B. Braun SE, Insulet Corporation, ICU Medical, Inc., Tandem Diabetes Care, Inc., Ypsomed, Fresenius Kabi AG, JMS Co., Ltd., Polymedicure, Medtronic, F. Hoffmann-La Roche Ltd., Romsons, Terumo Corporation, Moog, Inc., Promed Technology Co., Limited, Medcaptain Medical Technology Co., Ltd. and Others.
Increasing Prevalence of Chronic Diseases, Increased Home Healthcare Use, Technology Advances and Smart Pump Adoption, Growth in Emerging Economies.
North America Infusion Pump Market share, 2024
Source: NextGen Intelligence Stats and Consulting LLP
The North America region accounted for largest market share in the infusion pump market due to the presence of advanced health infrastructure and a rising prevalence of chronic diseases. The US is specially one of the prime contributors to this market. The increased adoption of advanced infusion technologies and the requirement of home healthcare services are favourably influencing this market.
The Asia-Pacific is the fastest emerging region in the market, attributed to the escalating investment in healthcare infrastructure and escalating numbers of chronic conditions. The WHO estimates that the Asia-Pacific region will expand 50% in healthcare spending by 2030. China and India lead the way in this growth, with significant investment in the improvement of healthcare facilities and enhancement of availability of medical technologies.
1.1. Introduction
1.2. Report Description & Objective
1.3. Assumption And Limitation
2.1. Data Collection
2.2. Primary Research & Secondary Research
2.3. Bottom-Up Approach & Top-Down Approach
2.4. Market Analysis & Size Estimation
2.5. Quality Check & Final Review
4.1. Top Trends To Watch
4.2. Top Strategies Followed By Key Players
4.3. Top Investment Pockets
5.1. Market Definition
5.2. Market Drivers
5.3. Market Restraints & Challenges
5.4. Market Opportunities
6.1. Porter’s Five Forces’ Analysis
6.2. Value Chain Analysis / Supply Chain Analysis
6.3. PESTLE Analysis
6.4. Regulatory Landscape
6.5. Pricing Analysis
7.1. Global Infusion Pump Market, By Product Type
7.2. Global Infusion Pump Market Attractiveness, By Product Type
7.2.1. Volumetric Infusion Pumps
7.2.2. Syringe Infusion Pumps
7.2.3. Patient-Controlled Analgesia Pumps
7.2.4. Enteral Infusion Pumps
7.2.5. Insulin Infusion Pumps
8.1. Global Infusion Pump Market, By Application
8.2. Global Infusion Pump Market Attractiveness, By Application
8.2.1. Oncology
8.2.2. Diabetes
8.2.3. Pain Management
8.2.4. Chemotherapy
8.2.5. Pediatric Applications
9.1. Global Infusion Pump Market, By End User
9.2. Global Infusion Pump Market Attractiveness, By End User
9.2.1. Hospitals
9.2.2. Home Care Settings
9.2.3. Ambulatory Surgical Centers
9.2.4. Long-term Care Facilities
10.1. Global Infusion Pump Market, By Technology
10.2. Global Infusion Pump Market Attractiveness, By Technology
10.2.1. Smart Infusion Pumps
10.2.2. Traditional Infusion Pumps
10.2.3. Wireless Infusion Pumps
10.2.4. Ambulatory Infusion Pumps
11.1. Global Infusion Pump Market, By Geography
11.2. Global Infusion Pump Market Attractiveness, By Geography
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Middle East & Africa
11.2.5. Latin America
12.1. North America Market Overview, By Countries
12.2. Market Overview, By Type
12.3. Market Overview, By Product Type
12.3.1. United States
12.3.2. Canada
13.1. Europe Market Overview, By Countries
13.2. Market Overview, By Type
13.3. Market Overview, By Product Type
13.3.1. Germany
13.3.2. France
13.3.3. UK
13.3.4. Italy
13.3.5. Spain
13.3.6. Rest of Europe
14.1. Asia Pacific Market Overview, By Countries
14.2. Market Overview, By Type
14.3. Market Overview, By Product Type
14.3.1. India
14.3.2. China
14.3.3. Japan
14.3.4. South Korea
14.3.5. Rest of Asia Pacific
15.1. Middle East & Africa Market Overview, By Countries
15.2. Market Overview, By Type
15.3. Market Overview, By Product Type
15.3.1. GCC
15.3.2. South Africa
15.3.3. Rest of Middle East & Africa
16.1. South America Market Overview, By Countries
16.2. Market Overview, By Type
16.3. Market Overview, By Product Type
16.3.1. Brazil
16.3.2. Argentina
16.3.3. Rest of South America
17.1. Key Developments
17.1.1. Partnerships, Collaborations, Agreements
17.1.2. Mergers & Acquisitions
17.1.3. New Product Developments
17.1.4. Other Developments
17.2. Company Share Analysis
17.3. Company Profiles
17.3.1. Abbott Laboratories
17.3.1.1. Company Overview
17.3.1.2. Product Overview
17.3.1.3. Financial Insights
17.3.1.4. Recent Developments
17.3.1.5. SWOT Analysis
17.3.2. Hospira
17.3.3. CME Medical
17.3.4. Alpha Therapeutics
17.3.5. Mindray
17.3.6. Johnson and Johnson
17.3.7. Terumo
17.3.8. ICU Medical
17.3.9. Codman and Shurtleff
17.3.10. Braun
17.3.11. Medtronic
Data Collection
Primary Research & Secondary Research
Bottom-Up Approach & Top-Down Approach
Market Analysis & Size Estimation
Quality Check & Final Review
By Product Type
• Volumetric Infusion Pumps
• Syringe Infusion Pumps
• Patient-Controlled Analgesia Pumps
• Enteral Infusion Pumps
• Insulin Infusion Pumps
By Application
• Oncology
• Diabetes
• Pain Management
• Chemotherapy
• Pediatric Applications
By End User
• Hospitals
• Home Care Settings
• Ambulatory Surgical Centers
• Long-term Care Facilities
By Technology
• Smart Infusion Pumps
• Traditional Infusion Pumps
• Wireless Infusion Pumps
• Ambulatory Infusion Pumps
© NextGen Intelligence Stats and Consulting LLP All rights reserved.
